12/23/2009
URL PHARMA LAUNCHES COLCRYS® PATIENT ASSISTANCE PROGRAM
Read More
12/23/2009
URL PHARMA LAUNCHES CO-PAY ASSISTANCE PROGRAM FOR COLCRYS®
Read More
12/16/2009
URL PHARMA ANNOUNCES FDA APPROVAL OF DONEPEZIL HYDROCHLORIDE (ARICEPT®) ORALLY DISINTEGRATING TABLETS FOR TREATMENT OF ALZHEIMER’S-RELATED DEMENTIA
Read More
12/8/2009
FACTS ABOUT COLCRYS® (COLCHICINE, USP) TABLETS AND UNAPPROVED DRUGS
The first and only single ingredient colchicine product approved by the FDA
Read More
11/2/2009
URL PHARMA LAUNCHES FIBRICOR™ (FENOFIBRIC ACID) FOR THE MANAGEMENT OF TRIGLYCERIDES AND CHOLESTEROL
Lower-Cost Alternative to TriLipix® (fenofibric acid) and Market-Leading Fibrate Therapy TriCor® (fenofibrate)
Read More
10/19/2009
NEW DATA PRESENTED AT ACR MEETING DEMONSTRATES COLCRYS™ (COLCHICINE, USP) SIGNIFICANTLY REDUCES PAIN OF ACUTE GOUT FLARE WITHIN 24 HOURS WITH SIDE EFFECTS COMPARABLE TO PLACEBO
Studies Confirm Clinical Benefit, Reveal New Information on Safety and Pharmacokinetics of Colcrys
Read More
10/19/2009
FDA APPROVES COLCRYS™ (COLCHICINE, USP) FOR PREVENTION OF GOUT FLARES
New Colchicine Formulation Significantly Reduces Side Effects, Maintains Full Efficacy; Now Indicated for Both Prophylaxis and Treatment of Gout Flares
Read More